Initial reactions (1st – 3rd...
Transcript of Initial reactions (1st – 3rd...
Background
Patientsn = 202 cases between 2007 & 2013
n = 176 🚺 n = 26 🚹 ∅ age: 44.5 (4-84)
Previous medication
Susanne Pannek-Rademacher, Mohinder Singh Jus, Felix Amsler, Jürgen PannekHomöopathie Pannek, Basel, SHI Homöopathie Praxis, Zug, Amsler Consulting, Basel, Neuro-Urologie, Schweizer Paraplegiker-Zentrum, Nottwil,
Switzerland
0
20
40
60
80
100
% Im
prov
emen
t
Indication
First Follow Up (max 2 mths) Last Follow Up (max 6 mths)
Conclusion
Indications/Improvements
Keep in mindCarcinosin
65
44 43 4035
0
10
20
30
40
50
60
70
Lyc Medo Sep Ign Nat-m
Dr. B.K. Bose-Stiftung
43%
34%
23%Cold
Melancholy
Eruption
24%
13% 27%
36%
No control
Change within6 mths
Control and change of remedy
Initial reactions (1st – 3rd month)
.
Our study demonstrates that Carcinosin is a long-acting remedy with a wide range of indications. It often replaced successfully Lycopodium which has certain similarities with Carcinosin. We find it to be a useful polychrest if no active cancer is present.
Apart from the classic monography by Fourbister, only few studies about Carcinosin are available. Therefore we analysed the clinical cases treated with Carcinosin in a single institution
Change within 7-12 mths
No change within 12 mths